반려동물 진단 시장 : 동물, 진단 기술, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Companion Animal Diagnostics Market was valued at USD 3.58 billion in 2023, expected to reach USD 3.90 billion in 2024, and is projected to grow at a CAGR of 9.39%, to USD 6.71 billion by 2030.

Companion animal diagnostics encompass a range of products and services designed to detect diseases, monitor health, and guide treatment plans for pets, such as dogs, cats, birds, and other domestic animals. The necessity for these diagnostics is driven by the increasing human-animal bond, rising pet ownership, and growing awareness of pet health and wellness. Applications include routine health assessments, disease diagnostics, genetic screening, and microbiome analyses, with end-users comprising veterinary clinics, pet owners, and research institutions. Market growth is influenced by the innovation of advanced diagnostic technologies, increasing expenditure on pet healthcare, and a rising prevalence of zoonotic diseases. Novel opportunities include the development of non-invasive diagnostic tools and point-of-care testing devices that offer rapid results, enhancing convenience for both veterinarians and pet owners. Integration of AI and machine learning in diagnostic solutions also presents significant potential by facilitating more precise and predictive animal health assessments.

However, market growth may be hindered by challenges such as high costs associated with advanced diagnostic tools and equipment, regulatory hurdles, and a dearth of skilled veterinary professionals. Furthermore, market penetration may be limited in developing regions due to a lack of awareness and infrastructure. For business growth, innovation in telemedicine and mobile health applications specifically designed for pet health monitoring is promising. Additionally, fostering collaboration with veterinary universities and research bodies can enhance product development and testing. The market is characterized by a tendency toward rapid technological advancements and high competitive dynamics, where players invest significantly in R&D to differentiate their offerings. Companies should focus on affordability, accessibility, and comprehensive diagnostic solutions to gain a competitive edge. Addressing regulatory compliance and expanding educational initiatives about the benefits of animal diagnostics can also propel market sustainability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Companion Animal Diagnostics Market

The Companion Animal Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing adoption of animals as companion
  • Increasing prevalence of infectious diseases and zoonotic diseases in animal
  • Government initiatives on animal healthcare and pet health policies
• Market Restraints
  • Expensive veterinary facilities and high cost of treatments
• Market Opportunities
  • Technology advancements in veterinary diagnostics
  • Emergence of biotechnological innovations
• Market Challenges
  • Lack of reimbursement policies for animal health care

Porter's Five Forces: A Strategic Tool for Navigating the Companion Animal Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Companion Animal Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Companion Animal Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Companion Animal Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Companion Animal Diagnostics Market

A detailed market share analysis in the Companion Animal Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Companion Animal Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Companion Animal Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Companion Animal Diagnostics Market

A strategic analysis of the Companion Animal Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Agrolabo SpA, Biomerieux SA, BioNote, Inc., Fujifilm Holdings Corporation, Heska Corporation, HyTest Ltd., IDEXX Laboratories, Inc., Idvet, Indical Bioscience GmbH, Neogen Corporation, Randox Laboratories, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Skyla Corporation, Thermo Fisher Scientific Inc., TriviumVet, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Companion Animal Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Animal, market is studied across Cat, Dog, and Horse.
• Based on Diagnostic Technology, market is studied across Clinical Biochemistry, Hematology, Immunodiagnostics, Molecular Diagnostics, and Urinalysis.
• Based on Applications, market is studied across Bacteriology, Clinical Pathology, Parasitology, and Virology.
• Based on End-Users, market is studied across Diagnostics Laboratories, Home-care, Research Institute, and Veterinary Clinics & Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing adoption of animals as companion
    • 5.1.1.2. Increasing prevalence of infectious diseases and zoonotic diseases in animal
    • 5.1.1.3. Government initiatives on animal healthcare and pet health policies
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive veterinary facilities and high cost of treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Technology advancements in veterinary diagnostics
    • 5.1.3.2. Emergence of biotechnological innovations
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of reimbursement policies for animal health care
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Companion Animal Diagnostics Market, by Animal

• 6.1. Introduction
• 6.2. Cat
• 6.3. Dog
• 6.4. Horse

7. Companion Animal Diagnostics Market, by Diagnostic Technology

• 7.1. Introduction
• 7.2. Clinical Biochemistry
• 7.3. Hematology
• 7.4. Immunodiagnostics
• 7.5. Molecular Diagnostics
• 7.6. Urinalysis

8. Companion Animal Diagnostics Market, by Applications

• 8.1. Introduction
• 8.2. Bacteriology
• 8.3. Clinical Pathology
• 8.4. Parasitology
• 8.5. Virology

9. Companion Animal Diagnostics Market, by End-Users

• 9.1. Introduction
• 9.2. Diagnostics Laboratories
• 9.3. Home-care
• 9.4. Research Institute
• 9.5. Veterinary Clinics & Hospitals

10. Americas Companion Animal Diagnostics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Companion Animal Diagnostics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Companion Animal Diagnostics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agrolabo SpA
• 2. Biomerieux SA
• 3. BioNote, Inc.
• 4. Fujifilm Holdings Corporation
• 5. Heska Corporation
• 6. HyTest Ltd.
• 7. IDEXX Laboratories, Inc.
• 8. Idvet
• 9. Indical Bioscience GmbH
• 10. Neogen Corporation
• 11. Randox Laboratories, Ltd.
• 12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 13. Skyla Corporation
• 14. Thermo Fisher Scientific Inc.
• 15. TriviumVet
• 16. Virbac S.A.
• 17. Zoetis Inc.